• Home
  • Pharmaceuticals and Healthcare
Covid-19 Rapid Diagnostic Test Market - Global Outlook and Forecast 2021-2027

Covid-19 Rapid Diagnostic Test Market - Global Outlook and Forecast 2021-2027

Report Code: KNJ687431 | No. of Pages: 106 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Apr-2021 
This report contains market size and forecasts of Covid-19 Rapid Diagnostic Test in Global, including the following market information:
Global Covid-19 Rapid Diagnostic Test Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Covid-19 Rapid Diagnostic Test market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Covid-19 Rapid Diagnostic Test companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Covid-19 Rapid Diagnostic Test Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Covid-19 Rapid Diagnostic Test Market Segment Percentages, By Type, 2020 (%)
Immunoassay
Genomic and WGS
rRT-PCR

China Covid-19 Rapid Diagnostic Test Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Covid-19 Rapid Diagnostic Test Market Segment Percentages, By Application, 2020 (%)
Hospital
Laboratory

Global Covid-19 Rapid Diagnostic Test Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Covid-19 Rapid Diagnostic Test Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Covid-19 Rapid Diagnostic Test Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Covid-19 Rapid Diagnostic Test Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Abbott Diagnostics
BD
Ador Diagnostics (BATM)
bioMérieux
Hardy Diagnostics
Applied BioCode
Biocartis SA
Cellmid
Akonni Biosystems
Alveo Technologies
Bio-Rad
Cepheid
Diasorin
Cue Health
Curetis
1 Introduction to Research & Analysis Reports
    1.1 Covid-19 Rapid Diagnostic Test Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Covid-19 Rapid Diagnostic Test Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Covid-19 Rapid Diagnostic Test Overall Market Size
    2.1 Global Covid-19 Rapid Diagnostic Test Market Size: 2021 VS 2027
    2.2 Global Covid-19 Rapid Diagnostic Test Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Covid-19 Rapid Diagnostic Test Players in Global Market
    3.2 Top Global Covid-19 Rapid Diagnostic Test Companies Ranked by Revenue
    3.3 Global Covid-19 Rapid Diagnostic Test Revenue by Companies
    3.4 Top 3 and Top 5 Covid-19 Rapid Diagnostic Test Companies in Global Market, by Revenue in 2020
    3.5 Global Companies Covid-19 Rapid Diagnostic Test Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Covid-19 Rapid Diagnostic Test Players in Global Market
        3.6.1 List of Global Tier 1 Covid-19 Rapid Diagnostic Test Companies
        3.6.2 List of Global Tier 2 and Tier 3 Covid-19 Rapid Diagnostic Test Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Covid-19 Rapid Diagnostic Test Market Size Markets, 2021 & 2027
        4.1.2 Immunoassay
        4.1.3 Genomic and WGS
        4.1.4 rRT-PCR
    4.2 By Type - Global Covid-19 Rapid Diagnostic Test Revenue & Forecasts
        4.2.1 By Type - Global Covid-19 Rapid Diagnostic Test Revenue, 2016-2021
        4.2.2 By Type - Global Covid-19 Rapid Diagnostic Test Revenue, 2022-2027
        4.2.3 By Type - Global Covid-19 Rapid Diagnostic Test Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Covid-19 Rapid Diagnostic Test Market Size, 2021 & 2027
        5.1.2 Hospital
        5.1.3 Laboratory
    5.2 By Application - Global Covid-19 Rapid Diagnostic Test Revenue & Forecasts
        5.2.1 By Application - Global Covid-19 Rapid Diagnostic Test Revenue, 2016-2021
        5.2.2 By Application - Global Covid-19 Rapid Diagnostic Test Revenue, 2022-2027
        5.2.3 By Application - Global Covid-19 Rapid Diagnostic Test Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global Covid-19 Rapid Diagnostic Test Market Size, 2021 & 2027
    6.2 By Region - Global Covid-19 Rapid Diagnostic Test Revenue & Forecasts
        6.2.1 By Region - Global Covid-19 Rapid Diagnostic Test Revenue, 2016-2021
        6.2.2 By Region - Global Covid-19 Rapid Diagnostic Test Revenue, 2022-2027
        6.2.3 By Region - Global Covid-19 Rapid Diagnostic Test Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America Covid-19 Rapid Diagnostic Test Revenue, 2016-2027
        6.3.2 US Covid-19 Rapid Diagnostic Test Market Size, 2016-2027
        6.3.3 Canada Covid-19 Rapid Diagnostic Test Market Size, 2016-2027
        6.3.4 Mexico Covid-19 Rapid Diagnostic Test Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe Covid-19 Rapid Diagnostic Test Revenue, 2016-2027
        6.4.2 Germany Covid-19 Rapid Diagnostic Test Market Size, 2016-2027
        6.4.3 France Covid-19 Rapid Diagnostic Test Market Size, 2016-2027
        6.4.4 U.K. Covid-19 Rapid Diagnostic Test Market Size, 2016-2027
        6.4.5 Italy Covid-19 Rapid Diagnostic Test Market Size, 2016-2027
        6.4.6 Russia Covid-19 Rapid Diagnostic Test Market Size, 2016-2027
        6.4.7 Nordic Countries Covid-19 Rapid Diagnostic Test Market Size, 2016-2027
        6.4.8 Benelux Covid-19 Rapid Diagnostic Test Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia Covid-19 Rapid Diagnostic Test Revenue, 2016-2027
        6.5.2 China Covid-19 Rapid Diagnostic Test Market Size, 2016-2027
        6.5.3 Japan Covid-19 Rapid Diagnostic Test Market Size, 2016-2027
        6.5.4 South Korea Covid-19 Rapid Diagnostic Test Market Size, 2016-2027
        6.5.5 Southeast Asia Covid-19 Rapid Diagnostic Test Market Size, 2016-2027
        6.5.6 India Covid-19 Rapid Diagnostic Test Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America Covid-19 Rapid Diagnostic Test Revenue, 2016-2027
        6.6.2 Brazil Covid-19 Rapid Diagnostic Test Market Size, 2016-2027
        6.6.3 Argentina Covid-19 Rapid Diagnostic Test Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Covid-19 Rapid Diagnostic Test Revenue, 2016-2027
        6.7.2 Turkey Covid-19 Rapid Diagnostic Test Market Size, 2016-2027
        6.7.3 Israel Covid-19 Rapid Diagnostic Test Market Size, 2016-2027
        6.7.4 Saudi Arabia Covid-19 Rapid Diagnostic Test Market Size, 2016-2027
        6.7.5 UAE Covid-19 Rapid Diagnostic Test Market Size, 2016-2027
7 Players Profiles
    7.1 Abbott Diagnostics
        7.1.1 Abbott Diagnostics Corporate Summary
        7.1.2 Abbott Diagnostics Business Overview
        7.1.3 Abbott Diagnostics Covid-19 Rapid Diagnostic Test Major Product Offerings
        7.1.4 Abbott Diagnostics Covid-19 Rapid Diagnostic Test Revenue in Global (2016-2021)
        7.1.5 Abbott Diagnostics Key News
    7.2 BD
        7.2.1 BD Corporate Summary
        7.2.2 BD Business Overview
        7.2.3 BD Covid-19 Rapid Diagnostic Test Major Product Offerings
        7.2.4 BD Covid-19 Rapid Diagnostic Test Revenue in Global (2016-2021)
        7.2.5 BD Key News
    7.3 Ador Diagnostics (BATM)
        7.3.1 Ador Diagnostics (BATM) Corporate Summary
        7.3.2 Ador Diagnostics (BATM) Business Overview
        7.3.3 Ador Diagnostics (BATM) Covid-19 Rapid Diagnostic Test Major Product Offerings
        7.3.4 Ador Diagnostics (BATM) Covid-19 Rapid Diagnostic Test Revenue in Global (2016-2021)
        7.3.5 Ador Diagnostics (BATM) Key News
    7.4 bioMérieux
        7.4.1 bioMérieux Corporate Summary
        7.4.2 bioMérieux Business Overview
        7.4.3 bioMérieux Covid-19 Rapid Diagnostic Test Major Product Offerings
        7.4.4 bioMérieux Covid-19 Rapid Diagnostic Test Revenue in Global (2016-2021)
        7.4.5 bioMérieux Key News
    7.5 Hardy Diagnostics
        7.5.1 Hardy Diagnostics Corporate Summary
        7.5.2 Hardy Diagnostics Business Overview
        7.5.3 Hardy Diagnostics Covid-19 Rapid Diagnostic Test Major Product Offerings
        7.5.4 Hardy Diagnostics Covid-19 Rapid Diagnostic Test Revenue in Global (2016-2021)
        7.5.5 Hardy Diagnostics Key News
    7.6 Applied BioCode
        7.6.1 Applied BioCode Corporate Summary
        7.6.2 Applied BioCode Business Overview
        7.6.3 Applied BioCode Covid-19 Rapid Diagnostic Test Major Product Offerings
        7.6.4 Applied BioCode Covid-19 Rapid Diagnostic Test Revenue in Global (2016-2021)
        7.6.5 Applied BioCode Key News
    7.7 Biocartis SA
        7.7.1 Biocartis SA Corporate Summary
        7.7.2 Biocartis SA Business Overview
        7.7.3 Biocartis SA Covid-19 Rapid Diagnostic Test Major Product Offerings
        7.4.4 Biocartis SA Covid-19 Rapid Diagnostic Test Revenue in Global (2016-2021)
        7.7.5 Biocartis SA Key News
    7.8 Cellmid
        7.8.1 Cellmid Corporate Summary
        7.8.2 Cellmid Business Overview
        7.8.3 Cellmid Covid-19 Rapid Diagnostic Test Major Product Offerings
        7.8.4 Cellmid Covid-19 Rapid Diagnostic Test Revenue in Global (2016-2021)
        7.8.5 Cellmid Key News
    7.9 Akonni Biosystems
        7.9.1 Akonni Biosystems Corporate Summary
        7.9.2 Akonni Biosystems Business Overview
        7.9.3 Akonni Biosystems Covid-19 Rapid Diagnostic Test Major Product Offerings
        7.9.4 Akonni Biosystems Covid-19 Rapid Diagnostic Test Revenue in Global (2016-2021)
        7.9.5 Akonni Biosystems Key News
    7.10 Alveo Technologies
        7.10.1 Alveo Technologies Corporate Summary
        7.10.2 Alveo Technologies Business Overview
        7.10.3 Alveo Technologies Covid-19 Rapid Diagnostic Test Major Product Offerings
        7.10.4 Alveo Technologies Covid-19 Rapid Diagnostic Test Revenue in Global (2016-2021)
        7.10.5 Alveo Technologies Key News
    7.11 Bio-Rad
        7.11.1 Bio-Rad Corporate Summary
        7.11.2 Bio-Rad Business Overview
        7.11.3 Bio-Rad Covid-19 Rapid Diagnostic Test Major Product Offerings
        7.11.4 Bio-Rad Covid-19 Rapid Diagnostic Test Revenue in Global (2016-2021)
        7.11.5 Bio-Rad Key News
    7.12 Cepheid
        7.12.1 Cepheid Corporate Summary
        7.12.2 Cepheid Business Overview
        7.12.3 Cepheid Covid-19 Rapid Diagnostic Test Major Product Offerings
        7.12.4 Cepheid Covid-19 Rapid Diagnostic Test Revenue in Global (2016-2021)
        7.12.5 Cepheid Key News
    7.13 Diasorin
        7.13.1 Diasorin Corporate Summary
        7.13.2 Diasorin Business Overview
        7.13.3 Diasorin Covid-19 Rapid Diagnostic Test Major Product Offerings
        7.13.4 Diasorin Covid-19 Rapid Diagnostic Test Revenue in Global (2016-2021)
        7.13.5 Diasorin Key News
    7.14 Cue Health
        7.14.1 Cue Health Corporate Summary
        7.14.2 Cue Health Business Overview
        7.14.3 Cue Health Covid-19 Rapid Diagnostic Test Major Product Offerings
        7.14.4 Cue Health Covid-19 Rapid Diagnostic Test Revenue in Global (2016-2021)
        7.14.5 Cue Health Key News
    7.15 Curetis
        7.15.1 Curetis Corporate Summary
        7.15.2 Curetis Business Overview
        7.15.3 Curetis Covid-19 Rapid Diagnostic Test Major Product Offerings
        7.15.4 Curetis Covid-19 Rapid Diagnostic Test Revenue in Global (2016-2021)
        7.15.5 Curetis Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer


List of Tables and Figures
Ask Sample Report to get more details…

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com